TRIB2 promotes pulmonary artery smooth muscle cell proliferation in pulmonary hypertension through SERCA2 ubiquitination

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Wenkang Zhang

Zhongda Hospital, Southeast University, Nanjing (China)

6 More presentations in this session

Presentation thumbnail

The effect of wedge pressure on the pulmonary compliance to resistance relationship

Doctor H. Kempton (Munich, DE)

Abstract Slides Video

Presentation thumbnail

CTRP7 as a molecular biomarker for predicting responsiveness to pulmonary vasodilators: insights from human and animal studies in pulmonary arterial hypertension.

Doctor K. Yamada (Sendai, JP)

Abstract Slides Video

Presentation thumbnail

Progesterone preserves eNOS coupling and supports endothelium-dependent vasodilation in the pulmonary artery of female rats: a potential therapeutic strategy for pulmonary arterial hypertension

Doctor D. Lyu (Chongqing, CN)

Abstract Slides Video

Presentation thumbnail

Single-nuclei transcriptomics uncovers right ventricular adaptation to pulmonary hypertension

Mr G. Bonazza (Zurich, CH)

Abstract Slides Video

Presentation thumbnail

Activation of prostaglandin E2 receptor 4 ameliorates pulmonary vascular remodeling and pulmonary hypertension via suppression of MEK/ERK activation

Doctor K. Kimuro (Fukuoka, JP)

Abstract Slides Video

Access the full session

Session thumbnail

From vascular remodelling to ventricular dysfunction: new insights into pulmonary hypertension

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Pathobiology of pulmonary hypertension

Congress Session

Molecular approaches to the treatment of pulmonary hypertension

Congress Session

Novel insights into vascular remodelling

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources